CRISPR Therapeutics AG - Common Shares (CRSP)
42.12
+0.13 (0.31%)
Crispr Therapeutics is a biopharmaceutical company that focuses on developing transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 gene editing technology
The company aims to harness the potential of genetic editing to treat various conditions, including genetic disorders, cancer, and autoimmune diseases. Through a combination of innovative research and strategic collaborations, Crispr Therapeutics is dedicated to advancing its pipeline of therapies and ultimately improving patient outcomes and quality of life.
| Previous Close | 41.99 |
|---|---|
| Open | 42.55 |
| Bid | 41.88 |
| Ask | 42.25 |
| Day's Range | 41.94 - 43.48 |
| 52 Week Range | 36.52 - 75.91 |
| Volume | 1,425,874 |
| Market Cap | 3.32B |
| PE Ratio (TTM) | -9.683 |
| EPS (TTM) | -4.4 |
| Dividend & Yield | N/A (N/A) |
| 1 Month Average Volume | 2,479,757 |
